About Actym Therapeutics
Actym Therapeutics is a private company based in Berkeley, California. It has reported $25,344,381 raised in two offerings on Form D since April 2020. Its chief executive is Christopher Thanos.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 28, 2023 | Jul 6, 2023 | $11,238,333of $27.5M target | 5 | $2.2M | EquityRule 506(b) | Form D ↗ |
| Mar 27, 2020 | Apr 9, 2020 | $14,106,048of $41.1M target | 28 | $503K | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $25,344,381 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Actym Therapeutics's Form D filed Jul 6, 2023.
CT
Christopher Thanos
Chief Executive Officer and director
On every Form D that Actym Therapeutics has filed: 2 filings, from Apr 9, 2020 to Jul 6, 2023.
BC
Benjamin Chen
Director
First appears on the Form D that Actym Therapeutics filed on July 6, 2023; on 1 of its 2 filings.
RM
Ron Mazumder
Director
First appears on the Form D that Actym Therapeutics filed on July 6, 2023; on 1 of its 2 filings.
JC
Julie Cherrington
Director
First appears on the Form D that Actym Therapeutics filed on July 6, 2023; on 1 of its 2 filings.
KD
Kanad Das
Director
On every Form D that Actym Therapeutics has filed: 2 filings, from Apr 9, 2020 to Jul 6, 2023.
Earlier filings also listed
- James Huang · directorLast listed on the Form D that Actym Therapeutics filed on April 9, 2020; on 1 of its 2 filings.
- Amit Kumar · director and promoterLast listed on the Form D that Actym Therapeutics filed on April 9, 2020; on 1 of its 2 filings.